Status:
RECRUITING
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Lead Sponsor:
InSightec
Conditions:
Uterine Fibroid
Eligibility:
FEMALE
18-50 years
Brief Summary
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Detailed Description
This is an observational study only for all consented subjects who undergo an Exablate treatment. The Exablate procedure is a commercial treatment. The objective of this registry is to collect data ab...
Eligibility Criteria
Inclusion
- - Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system.
Exclusion
Key Trial Info
Start Date :
February 16 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05386615
Start Date
February 16 2016
End Date
December 31 2026
Last Update
April 30 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095
2
Stanford University
Stanford, California, United States, 94305
3
Mayo Clinic
Rochester, Minnesota, United States, 55905
4
Huashan Hospital Affiliated to Fudan University
Shanghai, China